Gastrointestinal Disorder Therapeutics Market Report

Global and Region Gastrointestinal Disorder Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：168
  • REPORT CODE：GMM987468
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastrointestinal Disorder Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Disorder Therapeuticsmarket, defines the market attractiveness level of Gastrointestinal Disorder Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastrointestinal Disorder Therapeutics industry, describes the types of Gastrointestinal Disorder Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Disorder Therapeutics market and the development prospects and opportunities of Gastrointestinal Disorder Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Disorder Therapeutics market in Chapter 13.

    By Player:

    • Johnson & Johnson

    • UCB

    • Salix Pharmaceuticals

    • Takeda Pharmaceutical

    • AstraZeneca

    • Astellas Pharma

    • Bayer

    • Allergan

    • GlaxoSmithKline

    • Abbott Laboratories

    • Valeant Pharmaceuticals

    • AbbVie

    • Eisai

    By Type:

    • Irritable Bowel Syndrome (IBS)

    • Chronic Constipation (CC)

    • Ulcerative Colitis (UC)

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastrointestinal Disorder Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastrointestinal Disorder Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastrointestinal Disorder Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastrointestinal Disorder Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastrointestinal Disorder Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    • 7.2 United States Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    • 7.3 Europe Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    • 7.4 China Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    • 7.5 Japan Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    • 7.6 India Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Gastrointestinal Disorder Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Gastrointestinal Disorder Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastrointestinal Disorder Therapeutics Consumption Forecast (2022-2028)

    9 Global Gastrointestinal Disorder Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastrointestinal Disorder Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chronic Constipation (CC) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Ulcerative Colitis (UC) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastrointestinal Disorder Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastrointestinal Disorder Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Chronic Constipation (CC) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Ulcerative Colitis (UC) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastrointestinal Disorder Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastrointestinal Disorder Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastrointestinal Disorder Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastrointestinal Disorder Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastrointestinal Disorder Therapeutics Market Competitive Analysis

    • 14.1 Johnson & Johnson

      • 14.1.1 Johnson & Johnson Company Details

      • 14.1.2 Johnson & Johnson Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Product and Service

    • 14.2 UCB

      • 14.2.1 UCB Company Details

      • 14.2.2 UCB Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 UCB Gastrointestinal Disorder Therapeutics Product and Service

    • 14.3 Salix Pharmaceuticals

      • 14.3.1 Salix Pharmaceuticals Company Details

      • 14.3.2 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Service

    • 14.4 Takeda Pharmaceutical

      • 14.4.1 Takeda Pharmaceutical Company Details

      • 14.4.2 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product and Service

    • 14.5 AstraZeneca

      • 14.5.1 AstraZeneca Company Details

      • 14.5.2 AstraZeneca Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AstraZeneca Gastrointestinal Disorder Therapeutics Product and Service

    • 14.6 Astellas Pharma

      • 14.6.1 Astellas Pharma Company Details

      • 14.6.2 Astellas Pharma Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Product and Service

    • 14.7 Bayer

      • 14.7.1 Bayer Company Details

      • 14.7.2 Bayer Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Gastrointestinal Disorder Therapeutics Product and Service

    • 14.8 Allergan

      • 14.8.1 Allergan Company Details

      • 14.8.2 Allergan Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Allergan Gastrointestinal Disorder Therapeutics Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product and Service

    • 14.10 Abbott Laboratories

      • 14.10.1 Abbott Laboratories Company Details

      • 14.10.2 Abbott Laboratories Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product and Service

    • 14.11 Valeant Pharmaceuticals

      • 14.11.1 Valeant Pharmaceuticals Company Details

      • 14.11.2 Valeant Pharmaceuticals Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Valeant Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Service

    • 14.12 AbbVie

      • 14.12.1 AbbVie Company Details

      • 14.12.2 AbbVie Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AbbVie Gastrointestinal Disorder Therapeutics Product and Service

    • 14.13 Eisai

      • 14.13.1 Eisai Company Details

      • 14.13.2 Eisai Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Eisai Gastrointestinal Disorder Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastrointestinal Disorder Therapeutics

    • Figure Gastrointestinal Disorder Therapeutics Picture

    • Table Global Gastrointestinal Disorder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Disorder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Disorder Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastrointestinal Disorder Therapeutics Consumption by Country (2017-2022)

    • Figure United States Gastrointestinal Disorder Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Gastrointestinal Disorder Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Gastrointestinal Disorder Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastrointestinal Disorder Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Gastrointestinal Disorder Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastrointestinal Disorder Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Disorder Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastrointestinal Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Constipation (CC) Consumption and Growth Rate (2017-2022)

    • Figure Global Ulcerative Colitis (UC) Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Constipation (CC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ulcerative Colitis (UC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastrointestinal Disorder Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastrointestinal Disorder Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Gastrointestinal Disorder Therapeutics Product and Service

    • Table UCB (Foundation Year, Company Profile and etc.)

    • Table UCB Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB Gastrointestinal Disorder Therapeutics Product and Service

    • Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Service

    • Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Gastrointestinal Disorder Therapeutics Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Gastrointestinal Disorder Therapeutics Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Gastrointestinal Disorder Therapeutics Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Gastrointestinal Disorder Therapeutics Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Gastrointestinal Disorder Therapeutics Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Gastrointestinal Disorder Therapeutics Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Gastrointestinal Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Gastrointestinal Disorder Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US